Former Teva Pharmaceuticals CEO Dr. Jeremy Levin joins hosts Marc Cox and Kim St. Onge to discuss his book, Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust, highlighting China's accelerated goal to lead global pharmaceutical innovation by 2030. Levin emphasizes the critical need to preserve American biotechnology as a strategic national asset while separating young biotech startups from larger pharmaceutical companies. The conversation covers prescription drug pricing reform, long-outdated patent monopolies on essential drugs like insulin, generic drug enforcement, and the regulatory balance required between lower consumer costs and research funding.
LISTEN TO 97.1 FM TALK LIVE IN ST LOUIS OR STREAM WORLDWIDE AT 971TALK.COM
Hashtags:#971FMTalk #StLouis #STLNews #DrJeremyLevin #Biotech #Pharmaceuticals #ChinaCompetition #DrugPricing
